retatrutide clinical trial thailand patientsafety #publichealth #healthcareleadership #medicalethics #drugsafety #unapproveddrugs #clinicaltrials #npra #fda #weightlossdrugs #healthawareness Retatrutide, an experimental weight-loss drug,

After title and abstract screening, 35 studies progressed to full-text review (Fig

Some days she only managed protein shakes and Greek yogurt

Dipeptidyl peptidase 4 inhibitors and the risk of bullous pemphigoid among patients with type 2 diabetes

When patients respond inadequately to one GLP-1 agent, data now supports switching to or adding the complementary GLP-1/GIP dual agonist (tirzepatide) rather than introducing a second drug class like phentermine

The larger needle makes drawing the liquid easier

When to Contact a Healthcare Professional While moving a dose by 2 days is generally safe for most people, there are red flag symptoms that require immediate medical attention